Skint, with respect, the past history of promising announcements...

Skint, with respect, the past history of promising announcements has done little to lift the profile or share price of this company.

I too am a long term supporter, but you'd think that by now the company would have developed a profile to match their potential. With the market cap under $20mil, I think it's hard to argue that is does.

There are biotech's around that don't even come close to Solbec in terms of potential that have market cap's comparative or higher than Solbec's. While management have done well to progress the company this far on the money that has been spent, it means little if the share price is floundering and long term investors become disillusioned.

A great quote from Steve Carter that can be used to illustrate the point comes from http://www.mesotheleoma.com/solbec.htm

No date is given for the article, but from the way it reads, it's from sometime in 2002 (two years ago..!)

“We’ve got 160 million options out there exercisable in June 2003 at 20c. We would expect that those will be well and truly in the money and that they’ll be exercised … so by June next year we’d expect to have $30m in the bank.”

In June 2003, they expected the share price to be "well and truly" above 20c, but almost 16 months on, it's only half. Something is clearly wrong here.